The International Cancer Genome Consortium (ICGC) aims to catalog genomic abnormalities in tumors from 50 different cancer types. Genome sequencing reveals hundreds to thousands of somatic mutations in each tumor but only a minority of these drive tumor progression. We present the result of discussions within the ICGC on how to address the challenge of identifying mutations that contribute to oncogenesis, tumor maintenance or response to therapy, and recommend computational techniques to annotate somatic variants and predict their impact on cancer phenotype
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Somatic mutations and copy number alterations are the basis for cancer development and progression, ...
The International Cancer Genome Consortium (ICGC) aims to catalog genomic abnormalities in tumors fr...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer geno...
Genome-wide association studies have hitherto identified several common genetic variants that may si...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Somatic mutations and copy number alterations are the basis for cancer development and progression, ...
The International Cancer Genome Consortium (ICGC) aims to catalog genomic abnormalities in tumors fr...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer geno...
Genome-wide association studies have hitherto identified several common genetic variants that may si...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled syst...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Somatic mutations and copy number alterations are the basis for cancer development and progression, ...